References
- 중화인민공화국. 의료용 독성약품관리법. 1988.
- Kim, Ellie JY, Chen Y, Huang JQ, Li KM, Razmovski-Naumovski V, Poon J, Chan K, Roufogalis BD, McLachlan AJ, Moe SL, Yang D, Yao M, Liu Z, Li GQ. Evidence-based toxicity evaluation and scheduling of Chinese herbal medicines. Journal of Ethnopharmacology. 2013;146:40-61. https://doi.org/10.1016/j.jep.2012.12.027
- 식약처. 용역연구개발과제 식의약품 등 통합안전관리 기반연구 중 한약재 안전사용을 위한 등급별 차등관리 방안 연구. 2012.
- 박영철. 이선동. 한약의 안전성 등급화를 위한 evidence-based approach: Human equivalent dose-based the margin of safety. 대한예방한의학회지. 2013;17(3):1-12.
- 박영철, 이선동. 한약의 안전성 등급화를 통한 근거중심실용의학적 연구(1). J Korean Med. 2014;35(1):114-123. https://doi.org/10.13048/jkm.14011
- 박영철, 독성학의 분자-생화학적 원리, 한국학술정보(주), 2010. ISBN: 978-89-268-1259-4.
- 이선동, 박영철. 한약독성학 I. 한국학술정보(주). 2012. ISBN:978-89-268-3190-8.
- 이선동, 박영철. 한약독성학 II. 한국학술정보(주). 2013. ISBN. 978-89-268-4190-7
- Yan CC and Ryan J. Effects of Monocrotaline, a Pyrrolizidine Alkaloid, on glutathione Metabolism in the Rat. Huxtable Biochemical Pharmacology. 1996;51: 375-379. https://doi.org/10.1016/0006-2952(95)02189-2
- Jeffrey, AM, Williams GM. Risk assessment of DNA-reactive carcinogens in food. Toxicology and Applied Pharmacology. 2005;207:S628-S635. https://doi.org/10.1016/j.taap.2005.03.024
- Zhou S, Gao Y, Jiang W, Huang M, Xu A and Paxton JW. Interactions of Herbs with Cytochrome P450. Drug metabolism review. 2003;35(1):35-98. https://doi.org/10.1081/DMR-120018248
- Kim, Dong-Hyun Kim, Bok-Ryang Kim, Ji-Yeon Kim, Yo-Chan Jeong. Mechanism of covalent adduct formation of aucubin to proteins. Toxicology Letters. 2000;114:181-188. https://doi.org/10.1016/S0378-4274(99)00295-7
- Peter J. Vit. Approximate lethal dose versus median lethal dose in acute toxicity testing of pharmaceuticals. A retrospective study. Arch Toxicol. 1989;63(4):343-4. https://doi.org/10.1007/BF00278650
- Reagan-Shaw S, Nihal M, Ahmad N. Dose translation from animal to human studies revisited. Journal of the Federation of American Societies for Experimental Biology. 2008;22:659-661. https://doi.org/10.1096/fj.07-9574LSF
- Beasley V. Introduction to Toxicology. International Veterinary Information Service, Ithaca, New York, USA. 1999.
- www.clearsynth.com/docs/MSD-CS-PH-0626
- Dietz BM. Bolton JL. Biological reactive intermediates(BRIs) formed from botanicaldietary supplements. Chemico-Biological Interactions. 2011;192:72-80. https://doi.org/10.1016/j.cbi.2010.10.007
- Makingcosmetics-MSDS. www.makingcosmetics.com
-
US FDA. Safrole. 1989. PART 189-SUBSTANCES PROHIBITED FROM USE IN HUMAN FOOD,
$\S$ 189.180. - Johnson BM, van Breemen RB. In vitro formation of quinoid metabolites of the dietary supplement Cimicifuga racemosa (black cohosh). Chem. Res. Toxicol. 2003;16(7):838-884. https://doi.org/10.1021/tx020108n
- US FDA. FDA Poisonous Plant Database-Toxicity of medicinal herbal preparations. 2008.
- Editorial Committee of Chinese Materia Medica. State Drug Administration of China. Chinese Materia Medica. Shanghai: Science and Technology Press; 1998.
- Isbrucker RA, Burdock GA. Risk and safety assessment on the consumption of Licorice root (Glycyrrhiza sp.), its extract and powder as a food ingredient, with emphasis on the pharmacology and toxicology of glycyrrhizin. Regulatory Toxicology and Pharmacology. 2006;46:167-192. https://doi.org/10.1016/j.yrtph.2006.06.002
- MAFCO WORLDWIDE CORPORATION, Product Data Sheet, www.in-cosmeticsasia.com
- Materia Medica Group. Medical Vacational College of Northern Henan. Pharmacy Bulletin. 1982;17(2):114.